Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-4,021
Closed -$936K – 542
2024
Q3
$936K Buy
4,021
+374
+10% +$76.8K 0.02% 287
2024
Q2
$736K Sell
3,647
-5,200
-59% -$937K 0.02% 336
2024
Q1
$1.52M Sell
8,847
-200
-2% -$37.3K 0.04% 232
2023
Q4
$1.96M Sell
9,047
-5,353
-37% -$918K 0.06% 174
2023
Q3
$2.3M Buy
+14,400
New +$3.22M 0.04% 220

Other funds holding PODD

UBS O'Connor's PODD Position: Q4 2024 in Review

UBS O'Connor sold out of Insulet (PODD) in Q4 2024, closing a stake of 4,021 shares — an estimated $936K sold.

UBS O'Connor first reported a position in PODD in Q3 2023 and held it in 5 quarters. The position peaked at $2.3M in Q3 2023. 684 funds tracked by Wall St. Rank hold PODD as of Q4 2024.

  • UBS O'Connor reported no remaining Insulet position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 4,021 Insulet shares in Q4 2024, an estimated $936K.
  • UBS O'Connor first reported a position in Insulet in Q3 2023 and held it in 5 quarters.
  • UBS O'Connor's Insulet position peaked at $2.3M in Q3 2023.
  • 684 funds tracked by Wall St. Rank held Insulet as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.